Viewing Study NCT01054118


Ignite Creation Date: 2025-12-25 @ 5:00 AM
Ignite Modification Date: 2026-01-05 @ 3:47 PM
Study NCT ID: NCT01054118
Status: COMPLETED
Last Update Posted: 2013-09-04
First Post: 2010-01-15
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single Doses of JNJ-38431055, Sitagliptin, and Co-administration of JNJ-38431055 and Sitagliptin
Sponsor: Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2009-12
Start Date Type: None
Primary Completion Date: None
Primary Completion Date Type: None
Completion Date: 2010-02
Completion Date Type: ACTUAL
First Submit Date: 2010-01-15
First Submit QC Date: None
Study First Post Date: 2010-01-22
Study First Post Date Type: ESTIMATED
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2013-09-03
Last Update Post Date: 2013-09-04
Last Update Post Date Type: ESTIMATED